Home  |  Contact

UniProtKB/Swiss-Prot P25445: Variant p.Leu180Phe

Tumor necrosis factor receptor superfamily member 6
Gene: FAS
Variant information

Variant position:  180
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Unclassified
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Leucine (L) to Phenylalanine (F) at position 180 (L180F, p.Leu180Phe).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (L) to large size and aromatic (F)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In non-Hodgkin lymphoma; somatic mutation.
Any additional useful information about the variant.



Sequence information

Variant position:  180
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  335
The length of the canonical sequence.

Location on the sequence:   TSNTKCKEEGSRSNLGWLCL  L LLPIPLIVWVKRKEVQKTCR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TSNTKCKE----EGSRSNLGWLC--LL-LLPIPLIVWVKRKEVQKTCR

Rhesus macaque                TSNTKCKE----EDSRSDLLWLCLLLL-LLLIPPIVYVV--

Mouse                         TSNTNCRK----QSPRNRL-WLLTILVLLIPLVFIYRKY--

Rat                           TSNTKCKK----QSSNYKLLWLL-----ILPGLAILFVF--

Pig                           TSNTKCREVFQSAGSRSNLHWLWALLI-LIPVPALVYRE--

Bovine                        TSNTKCK------GSRSHANSLWALLILLIPIVLIIYKV--

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 26 – 335 Tumor necrosis factor receptor superfamily member 6
Transmembrane 174 – 190 Helical
Alternative sequence 87 – 335 Missing. In isoform 3.
Alternative sequence 104 – 335 Missing. In isoform 2.
Alternative sequence 133 – 335 Missing. In isoform 5.
Alternative sequence 150 – 335 Missing. In isoform 4.
Alternative sequence 169 – 189 Missing. In isoform 6.
Helix 174 – 181


Literature citations

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.
Groenbaek K.; Straten P.T.; Ralfkiaer E.; Ahrenkiel V.; Andersen M.K.; Hansen N.E.; Zeuthen J.; Hou-Jensen K.; Guldberg P.;
Blood 92:3018-3024(1998)
Cited for: VARIANTS NON-HODGKIN LYMPHOMA THR-25; PHE-180; LEU-183; ILE-198; VAL-260; LYS-264; LYS-272; PHE-278 AND ASN-299;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.